Mass spectrometry analysis of tryptic peptide complexes derived from α3α5-heterodimer and α4α4-homodimers. A, fraction P1 (Fig. 3) containing mainly α3α5-heterodimers was digested with trypsin and analyzed by LC-ESI/MS3. Left panel, ESI spectrum of the T-4481 complex constituted by NDYSYWLSTPEPMPMSMQPLK (T-2514) and KPIPSTVKOHAGELENIISR (T-1967) peptides. Multiply charged ions of the complex (+3, +4, +5, and +6) are indicated in red for better visualization. Right panel, MS/MS spectrum generated by fragmentation of the quintuply charged ion 897.8 m/z produces the 823.8 m/z and 1007.87 m/z ions. The 823.8 m/z is the triply charged ion for T*-2466 peptide, which represents the loss of 48 atomic mass units by the T-2514 peptide. The 1007.87 m/z is the doubly charged ion for T*-2013 peptide, which represents the gain of 46 atomic mass units by the T-1967 peptide. The asterisk indicates that such tryptic peptide contains a modified residue. The sequences of T*-2466 and T*-2013 peptides, including their amino acid modifications, were confirmed by further fragmentation (MS3) of 823.8 m/z and 1007.87 m/z ion, respectively (supplemental Fig. 9A). B, left panel, ESI spectrum of the T-3959 complex constituted by NDYSYWLSTPAMIPMDMAPITGR (T-2629) and PQSETLKOHAGDLR (T-1330) peptides. Multiply charged ions of the complex (+3, +4, and +5) are indicated in red for better visualization. Right panel, MS/MS spectrum generated by fragmentation of the 990.76 m/z ion produces the 1291.91 m/z and 688.90 m/z ions. The 1291.91 m/z is the doubly charged ion for T*-2581 peptide, which represents the loss of 48 atomic mass units by the T-2629 peptide. The 688.90 m/z is the doubly charged ion for the T*-1376 peptide, which represents the gain of 46 atomic mass units by the T-1330 peptide. The asterisk indicates that such tryptic peptide contains a modified residue. The sequence of T*-2581 and T*-1376 peptides, including their amino acid modifications, were confirmed by further fragmentation (MS3) of 1291.91 m/z and 688.90 m/z ions, respectively (supplemental Fig. 9B). C, LC-ESI/MS3 analysis of fraction P2 (Fig. 3), containing mainly α4α4-homodimers, after digestion with trypsin and Asp-N endoproteinase. Left panel, ESI spectrum of the TA-3665 complex constituted by STAPLPMTPLSEDEIRPY (TA-2016) and SAPLPDTLKESHAQR (TA-1649) peptides. Multiply charged ions of the complex (+3, +4, +5, and +6) are indicated in red for better visualization. Right panel, MS/MS spectrum generated by fragmentation of 917.1 m/z ion produces the 985.44 m/z and 848.60 m/z ions. The 985.44 m/z is the doubly charged ion for TA*-1968 peptide, which represent the loss of 48 atomic mass units by TA-2016 peptide. The 848.60 m/z is the doubly charged ion for the TA*-1695 peptide, which represents the gain of 46 atomic mass units by the TA-1649 peptide. The asterisk indicates that such peptide contains a modified residue. The sequences of TA*-1968 and TA*-1695 peptides, including their amino acid modifications, were confirmed by further fragmentation (MS3) of 985.44 m/z and 848.60 m/z ions, respectively (supplemental Fig. 9C).